dalteparin has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baetta, R; Camera, M; Comparato, C; Ezekowitz, MD; Fuortes, M; Paoletti, R; Rossi, F; Toschi, V; Tremoli, E | 1 |
1 other study(ies) available for dalteparin and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
| Article | Year |
|---|---|
Cholesterol-induced thrombogenicity of the vessel wall: inhibitory effect of fluvastatin.
Topics: Animals; Anticholesteremic Agents; Anticoagulants; Aorta; cdc42 GTP-Binding Protein; Cells, Cultured; Cholesterol; Diet, Atherogenic; Endothelium, Vascular; Enoxaparin; Fatty Acids, Monounsaturated; Fluvastatin; Gene Expression Regulation; Hemorheology; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; I-kappa B Proteins; Indoles; Male; NF-kappa B; NF-KappaB Inhibitor alpha; Platelet Adhesiveness; Protein Prenylation; Protein Processing, Post-Translational; Rabbits; RNA, Messenger; Signal Transduction; Thrombophilia; Thromboplastin; Transcription, Genetic; Tumor Necrosis Factor-alpha; Umbilical Veins | 2002 |